Tang V, Zhang K, Mirchia K, Lu R, Guney E, Terry M
Am J Surg Pathol. 2025; .
PMID: 39807609
PMC: 11892991.
DOI: 10.1097/PAS.0000000000002353.
Ono T, Hinz F, Tanaka S, Takahashi M, Nanjo H, von Deimling A
J Neurosurg Case Lessons. 2022; 3(14).
PMID: 36303507
PMC: 9379691.
DOI: 10.3171/CASE2260.
Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Hussen B, Babashah S
J Cell Mol Med. 2021; 26(2):287-305.
PMID: 34907642
PMC: 8743668.
DOI: 10.1111/jcmm.17126.
Chen H, He Y, Wen X, Shao S, Liu Y, Wang J
Front Oncol. 2021; 11:768264.
PMID: 34881182
PMC: 8645898.
DOI: 10.3389/fonc.2021.768264.
Korshunov A, Okonechnikov K, Schmitt-Hoffner F, Ryzhova M, Sahm F, Stichel D
Acta Neuropathol Commun. 2021; 9(1):20.
PMID: 33536079
PMC: 7860633.
DOI: 10.1186/s40478-021-01118-5.
SOX9: The master regulator of cell fate in breast cancer.
Jana S, Krishna B, Singhal J, Horne D, Awasthi S, Salgia R
Biochem Pharmacol. 2020; 174:113789.
PMID: 31911091
PMC: 9048250.
DOI: 10.1016/j.bcp.2019.113789.
The cell type resolved mouse transcriptome in neuron-enriched brain tissues from the hippocampus and cerebellum during prion disease.
Majer A, Medina S, Sorensen D, Martin M, Frost K, Phillipson C
Sci Rep. 2019; 9(1):1099.
PMID: 30705335
PMC: 6355796.
DOI: 10.1038/s41598-018-37715-z.
MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.
Wang Q, Zhou C, Zhan M, Tang J, Wang C, Ma C
Cell Death Dis. 2018; 9(7):752.
PMID: 29970901
PMC: 6030174.
DOI: 10.1038/s41419-018-0715-6.
Astrocytes, Microglia, and Parkinson's Disease.
Joe E, Choi D, An J, Eun J, Jou I, Park S
Exp Neurobiol. 2018; 27(2):77-87.
PMID: 29731673
PMC: 5934545.
DOI: 10.5607/en.2018.27.2.77.
Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
Thimsen V, John N, Buchfelder M, Flitsch J, Fahlbusch R, Stefanits H
Sci Rep. 2017; 7(1):15856.
PMID: 29158570
PMC: 5696533.
DOI: 10.1038/s41598-017-15977-3.
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.
Malladi S, Macalinao D, Jin X, He L, Basnet H, Zou Y
Cell. 2016; 165(1):45-60.
PMID: 27015306
PMC: 4808520.
DOI: 10.1016/j.cell.2016.02.025.
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.
Garros-Regulez L, Aldaz P, Arrizabalaga O, Moncho-Amor V, Carrasco-Garcia E, Manterola L
Expert Opin Ther Targets. 2016; 20(4):393-405.
PMID: 26878385
PMC: 4898154.
DOI: 10.1517/14728222.2016.1151002.
SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth.
Wang H, Lian P, Zheng P
Oncotarget. 2015; 6(24):20711-22.
PMID: 26036262
PMC: 4653037.
DOI: 10.18632/oncotarget.4133.
SOX9 accelerates ESC differentiation to three germ layer lineages by repressing SOX2 expression through P21 (WAF1/CIP1).
Yamamizu K, Schlessinger D, Ko M
Development. 2014; 141(22):4254-66.
PMID: 25371362
PMC: 4302912.
DOI: 10.1242/dev.115436.
Role of SOX family of transcription factors in central nervous system tumors.
Acanda de la Rocha A, Sampron N, Alonso M, Matheu A
Am J Cancer Res. 2014; 4(4):312-24.
PMID: 25057435
PMC: 4106650.
MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.
Xu J, Zhang W, Wan R, Yang Y
Tumour Biol. 2014; 35(10):9847-53.
PMID: 24989927
DOI: 10.1007/s13277-014-2229-x.
Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression.
Keasey M, Kang S, Lovins C, Hagg T
Cell Commun Signal. 2013; 11:35.
PMID: 23693126
PMC: 3691611.
DOI: 10.1186/1478-811X-11-35.
Regrowth of transected retinal ganglion cell axons despite persistent astrogliosis in the lizard (Gallotia galloti).
Romero-Aleman M, Monzon-Mayor M, Santos E, Yanes C
J Anat. 2013; 223(1):22-37.
PMID: 23656528
PMC: 4487760.
DOI: 10.1111/joa.12053.
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.
Cai C, Wang H, He H, Chen S, He L, Ma F
J Clin Invest. 2013; 123(3):1109-22.
PMID: 23426182
PMC: 3582143.
DOI: 10.1172/JCI66666.
Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.
Hagel C, Treszl A, Fehlert J, Harder J, von Haxthausen F, Kern M
J Neurooncol. 2013; 112(2):191-7.
PMID: 23371454
DOI: 10.1007/s11060-013-1062-1.